HSBC names Elizabeth Platt director from Oct. 1
Platt’s director and committee-member roles carry £271,150 in annual fees; her £150,000 annual chair fee is subject to regulatory approval.
Rhea-AI Filing Summary
HSBC Holdings plc announced Elizabeth Alison Platt’s appointment as an Independent non-executive Director effective October 1, 2026, subject to election by shareholders at the 2027 AGM. Upon appointment, she will join the Group Remuneration, Group Risk, and Nomination and Corporate Governance committees. The Board determined that she is independent.
Subject to regulatory approval, Platt will succeed Dame Carolyn Fairbairn as Group Remuneration Committee Chair on February 24, 2027, after HSBC publishes annual results on February 23. Her director and committee-member roles carry total fees of £271,150 per annum; she will receive £150,000 per annum upon appointment as committee chair, subject to regulatory approval. Platt spent 21 years at Bupa Group and was Chief Executive Officer of Countrywide plc for four years.
Positive
- None.
Negative
- None.
Key Figures
Total director and committee-member fees: £271,150 per annum
Independent non-executive Director fee: £136,500 per annum
Group Remuneration Committee member fee: £50,000 per annum
+2 more
5 metrics
Total director and committee-member fees
£271,150 per annum
For the independent non-executive director and committee-member roles
Independent non-executive Director fee
£136,500 per annum
Director role
Group Remuneration Committee member fee
£50,000 per annum
Committee membership
Group Risk Committee member fee
£50,000 per annum
Committee membership
Group Remuneration Committee Chair fee
£150,000 per annum
Upon appointment as Chair, subject to regulatory approval
Key Terms
Independent non-executive Director, Group Remuneration Committee, Directors’ remuneration policy, regulatory approval
4 terms
Independent non-executive Director regulatory
"appointment as an Independent non-executive Director"
An independent non-executive director is a board member who is not part of a company’s day-to-day management and has no close ties to major owners, so they can offer unbiased oversight of strategy, risks, and executive pay. For investors, they act like an impartial referee who helps prevent conflicts of interest, improve transparency and hold management accountable, which can reduce governance risk and protect shareholder value.
Group Remuneration Committee regulatory
"Chair of the Group Remuneration Committee"
Directors’ remuneration policy financial
"pursuant to the Directors’ remuneration policy"
regulatory approval regulatory
"subject to regulatory approval"
Regulatory approval is the official permission given by government agencies or authorities that allows a product, service, or business activity to be legally operated or sold. It is important to investors because receiving approval often indicates that a product has been reviewed for safety and compliance, which can influence its success and the company’s prospects in the market. Without this approval, launching or selling certain products may be restricted or prohibited.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When does HSBC Holdings plc (HSBC) add Elizabeth Alison Platt to its board?
HSBC announced that Elizabeth Alison Platt will become an Independent non-executive Director effective October 1, 2026, subject to election by shareholders at the 2027 Annual General Meeting. If elected, her initial three-year term will run from her election until the 2030 AGM.
What annual fees will Elizabeth Alison Platt receive from HSBC (HSBC)?
HSBC states that Platt’s total annual fees for her independent director and three committee-member roles are £271,150. The components are £136,500 for the director role, £50,000 each for the Group Remuneration and Group Risk committees, and £34,650 for the Nomination and Corporate Governance Committee; upon appointment as remuneration committee chair, she will receive £150,000 per annum, subject to regulatory approval.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FORM 6-K
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Report of Foreign Private Issuer
Pursuant to Rule 13a - 16 or 15d - 16 of
the Securities Exchange Act of 1934
For the
month of September
HSBC Holdings plc
8
Canada Square, London E14 5HQ, England
(Indicate
by check mark whether the registrant files or will file annual
reports under cover of Form 20-F or
Form 40-F).
Form
20-F X Form 40-F
25 September 2026
HSBC
HOLDINGS PLC
CHANGES TO BOARD AND COMMITTEE COMPOSITION
HSBC Holdings plc (‘HSBC’ or the ‘Company’)
has today announced the appointment of Elizabeth Alison Platt
(‘Alison’) (aged 64) as an Independent non-executive
Director with effect from 1 October 2026. Upon appointment she will
be a member of the Group Remuneration Committee, Group Risk
Committee and the Nomination and Corporate Governance
Committee.
The Board has also appointed Alison as Dame Carolyn
Fairbairn’s successor as Chair of the Group Remuneration
Committee, subject to regulatory approval. This follows
Carolyn’s appointment as Chair of HSBC UK Bank plc. Upon
receipt of regulatory approval, Alison will succeed Carolyn on 24
February 2027, following the publication of HSBC’s Annual
Results on 23 February 2027.
Alison brings substantial plc leadership and commercial experience
to the Board. Her executive career included 21 years at Bupa Group,
including in senior leadership roles across its international
businesses. She also brings extensive knowledge of the UK and
international business environment, gained as Chief Executive
Officer of Countrywide plc for four years. She has since
built extensive non-executive board experience in listed and plc
environments.
Together with non-executive experience she has led complex
businesses and brings strong expertise in financial services,
investor engagement, remuneration and corporate governance. She is
Chair of Ageas UK, Senior Independent Director of Inchcape plc and
a non-executive director of Spectrum Life, and was previously a
non-executive director of Tesco plc and Chair of Hargreaves
Lansdown plc.
In line with the UK and Hong Kong Corporate Governance Codes, the
Board have determined that Alison is independent. In making that
determination, the Board have concluded that there are no other
relationships or circumstances which are likely to affect her
judgements and that any relationships or circumstances which could
appear to do so are not considered to be material.
Commenting on the appointment, HSBC’s Group Chairman, Brendan
Nelson, said:
“Alison brings substantial commercial and listed-company
leadership experience to the Board, gained as both a chief
executive and a non-executive director. Her financial services
expertise, strategic perspective and experience of remuneration and
investor engagement will be valuable to the Board and will further
strengthen the Group Remuneration Committee. On behalf of the
Board, I’d like to thank Carolyn for her excellent leadership
of the Group Remuneration Committee over the last four and a half
years”
For and on behalf of
HSBC Holdings plc
Angela McEntee
Group
Company Secretary
HSBC Holdings plc
Registered Office and Group Head Office:
8
Canada Square, London E14 5HQ, United Kingdom
Web: www.hsbc.com
Incorporated in England and Wales with limited liability.
Registration number 617987.
Media enquiries to:
Neil
Fleming +44 (0) 7384 792051
neil1.fleming@hsbc.com
Supplementary Information:
Alison’s
appointment as a Director of the Company is subject to election by
shareholders at the 2027 Annual General Meeting (‘AGM’)
and annual re-election thereafter. Her initial three-year term will
run from her initial election, if successful, until the 2030
AGM.
As
an Independent non-executive Director, Alison will not have a
service contract with the Company and will be paid total fees of
£271,150 per annum pursuant to the Directors’
remuneration policy, approved by shareholders at the 2025 AGM. The
total per annum fees consists of: £136,500 for her role as
Independent non-executive Director, £50,000 for her role as a
member of the Group Remuneration Committee, £50,000 for her
role as a member of the Group Risk Committee and £34,650 for
her role as a member of the Nomination and Corporate Governance
Committee. Alison will receive a fee of £150,000 per annum
upon appointment as Chair of the Group Remuneration Committee,
subject to regulatory approval.
Current
and past listed company appointments:
●
Senior
Independent Director of Inchcape plc: 2 January 2024 –
Present.
●
Independent
non-executive director of Tesco plc: 1 April 2016 – 12 June
2025.
●
Independent
non-executive director of Dechra Pharmaceuticals Limited
(which subsequently de-listed in January 2024): 1 March 2020
– 16 January 2024.
●
Independent
non-executive director and Chair of Hargreaves Lansdown plc (which
subsequently de-listed in March 2025): 6 February 2024 – 24
March 2025.
Save as disclosed above, Alison has not held any directorships in
any other publicly listed companies, whether in London, Hong Kong
or overseas, during the previous five years. She does not have any
relationship with any directors, senior management, substantial or
controlling shareholders of the Company.
Alison has confirmed:
●
Her
respective independence as regards each of the factors referred to
in Rule 3.13(1) to (8) of the Hong Kong Listing Rules;
●
she
does not have any past or present financial or other interest in
the business of the Company or its subsidiaries or any connection
with any core connected person of the Company;
●
she
does not have any interests in the shares of the Company within the
meaning of Part XV of the Securities and Futures Ordinance;
and
●
that
there are no other factors that may affect her independence at the
time of her appointment.
There are no matters that need to be disclosed pursuant to Listing
Rule 6.4.8(1) to (6) of the Listing Rules of the Financial Conduct
Authority. Save as disclosed above there is no other information
required to be disclosed pursuant to Rule 13.51(2) of the Rules
Governing the Listing of Securities on the Stock Exchange of the
Hong Kong Limited.
Board of Directors
The Board of Directors of HSBC Holdings plc as at the date of this
announcement comprises: Brendan Robert Nelson*, Georges Bahjat
Elhedery, Geraldine Joyce Buckingham†, Wei Sun
Christianson†, Rachel Duan†, Dame Carolyn Julie
Fairbairn†, James Anthony Forese†, Steven Craig
Guggenheimer†, Manveen (Pam) Kaur, Dr José Antonio Meade
Kuribreña†, Richard Henry Meddings†, Kalpana
Jaisingh Morparia†, Eileen K Murray† and Swee Lian
Teo†.
* Independent non-executive Chairman
† Independent non-executive Director
HSBC Group
HSBC Holdings plc, the parent company of HSBC, is headquartered in
London. HSBC serves customers worldwide from offices in 56
countries and territories. With assets of US$3,438bn at 30 June
2026, HSBC is one of the world’s largest banking and
financial services organisations.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
HSBC
Holdings plc
|
|
|
|
|
|
|
By:
|
|
|
Name:
Angela McEntee
|
|
|
Title:
Group Company Secretary
|
|
|
|
|
|
Date:
25 September 2026
|